Cargando…
Drugs under preclinical and clinical study for treatment of acute and chronic lymphoblastic leukemia
Targeted therapy has modernized the treatment of both chronic and acute lymphoblastic leukemia. The introduction of monoclonal antibodies and combinational drugs has increased the survival rate of patients. Preclinical studies with various agents have resulted in positive outputs with Phase III tria...
Autores principales: | Jacob, Joe Antony, Salmani, Jumah Masoud Mohammad, Chen, Baoan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4920255/ https://www.ncbi.nlm.nih.gov/pubmed/27382259 http://dx.doi.org/10.2147/PPA.S109477 |
Ejemplares similares
-
Advances of wogonin, an extract from Scutellaria baicalensis, for the treatment of multiple tumors
por: Wu, Xue, et al.
Publicado: (2016) -
Apatinib exhibits anti-leukemia activity in preclinical models of acute lymphoblastic leukemia
por: Deng, Manman, et al.
Publicado: (2018) -
Prophylaxis and treatment of acute lymphoblastic leukemia relapse after allogeneic hematopoietic stem cell transplantation
por: Chen, Runzhe, et al.
Publicado: (2015) -
Advances in the drug therapies of acute myeloid leukemia (except acute wpromyelocytic leukemia)
por: Lin, Min, et al.
Publicado: (2018) -
The functional role of microRNA in acute lymphoblastic leukemia: relevance for diagnosis, differential diagnosis, prognosis, and therapy
por: Luan, Chengxin, et al.
Publicado: (2015)